{
"NDC": {
"NDCCode": "52536-485-37",
"PackageDescription": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52536-485-37) ",
"NDC11Code": "52536-0485-37",
"ProductNDC": "52536-485",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Verapamil Hydrochloride",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Verapamil Hydrochloride",
"DosageFormName": "CAPSULE, EXTENDED RELEASE",
"RouteName": "ORAL",
"StartMarketingDate": "20241126",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA AUTHORIZED GENERIC",
"ApplicationNumber": "NDA020943",
"LabelerName": "Wilshire Pharmaceuticals, Inc.",
"SubstanceName": "VERAPAMIL HYDROCHLORIDE",
"StrengthNumber": "100",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-11-30",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20241126",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}